Navigation Links
ONCOTHYREON APPOINTS JULIE M. EASTLAND AS CHIEF FINANCIAL OFFICER
Date:8/31/2010

SEATTLE, Aug. 31 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced the appointment of Julie M. Eastland as Chief Financial Officer and Vice President, Corporate Development, effective September 7, 2010. Ms. Eastland's responsibilities will include financial management, investor relations and business development.

"Ms. Eastland brings more than 25 years of financial management experience to Oncothyreon," said Robert L. Kirkman, M.D., President and CEO of Oncothyreon. "We are confident that this experience, coupled with her strategic planning and operational expertise in the biotechnology arena, will be an asset to our company, and we welcome her to our management team."

"I am delighted to join Oncothyreon and am looking forward to contributing to the company's development," said Ms. Eastland. "With the first interim look for the START trial of Stimuvax expected by year end, and with multiple Phase 2 trials for the PI-3 kinase inhibitor PX-866 being planned, it is an exciting time in Oncothyreon's history."

Ms. Eastland served as Chief Financial Officer and Vice President Finance and Operations of VLST Corporation, a privately-held biotechnology company, from February 2006 to 2010. From 2000 to 2005, Ms. Eastland held various finance positions at Dendreon Corporation, a publicly-traded biotechnology company, most recently as the Vice President of Strategic Planning. Prior to Dendreon, Ms. Eastland worked for Amgen, Inc. as area finance manager and assistant controller for its Colorado operations. Ms. Eastland has also worked as director of finance and planning for Encore Media Group, international finance and business manager and senior financial analyst for SCIENCE Magazine and financial manager for the Discovery Channel. Ms. Eastland received an M.B.A. from Edinburgh University Management School and a B.S. in finance from Colorado State Un
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncothyreon reports second quarter 2010 financial results
2. Oncothyreon announces second quarter 2010 financial results conference call
3. Oncothyreon announces presentations at upcoming investor conferences in June
4. Oncothyreon to present at the Rodman & Renshaw Annual Global Investment Conference
5. Oncothyreon reports full year and fourth quarter 2009 financial results
6. Oncothyreon reports first quarter 2010 financial results
7. Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono
8. Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement
9. Oncothyreons PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover
10. Oncothyreon reports third quarter 2009 financial results & provides product pipeline update
11. Oncothyreon announces webcast of third quarter 2009 financial results conference call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Mass. , April 1, 2015  EMD Serono, ... Germany , announced today the appointment of ... Medical Affairs, Neurology and Immunology. In this capacity, he ... and business development projects and collaborations for Rebif ® ... and Neurology pipeline. Dr. Munschauer joins ...
(Date:4/1/2015)... Canada,s Research-Based Pharmaceutical Companies (Rx&D) acknowledges ... on Cost Drivers of Public Drug Plans in ... the rates of change in drug costs have been steadily ... in 2012/13 for a number of select public drug plans. ... of medicines without considering their overall impact on the system ...
(Date:4/1/2015)... Synthetic Biologics, Inc. (NYSE MKT: SYN), ... and diseases, with a focus on protecting the ... development of SYN-004, the Company,s candidate therapy designed ... the gastrointestinal (GI) tract and maintain the natural ... of C. difficile infection, antibiotic-associated diarrhea ...
(Date:4/1/2015)... 2015 The concept of “spot reducing” areas ... industry. Founder of Fasciology, Ashley Black, says that even the ... instead of having to wait for the whole fat system ... prior to fat cooling procedures, the only well known ... liposuction, which is a highly invasive procedure.” It is common ...
Breaking Biology Technology:EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 2EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 3EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 4EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 5Rx&D responds to PMPRB report: overall impact of medicines must always be considered 2Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 2Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 3Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 4Hybrid Health Guru, Ashley Black, announces that her invention The FasciaBlaster™ rivals the “fat cooling” procedures that reduce exercise and diet resistant fat pockets. 2Hybrid Health Guru, Ashley Black, announces that her invention The FasciaBlaster™ rivals the “fat cooling” procedures that reduce exercise and diet resistant fat pockets. 3
... To validate any RNAi experiment, target mRNA , ... quantitated. Validation, , using a ... is required for optimization of transfection parameters. , ... effectiveness and potency of any siRNA sequence. Finally, , ...
... Neuronal and Other Hard-to-transfect Cells , ... Kevin Kelnar, David Brown, Ambion, Inc. , ... RNA interference (RNAi) is a powerful , ... genes. It is used routinely for gene function analysis, target , ...
... Non-coding small RNAs such as transfer RNAs , ... and small nuclear RNAs (snRNA) play critical roles in a , ... regulation of mRNA , translation, ... maintenance and gene imprinting. In addition, two novel , ...
Cached Biology Technology:Confirming RNAi Effects Is Now Easier Than Ever 2Confirming RNAi Effects Is Now Easier Than Ever 3Confirming RNAi Effects Is Now Easier Than Ever 4Confirming RNAi Effects Is Now Easier Than Ever 5Delivering siRNAs to Difficult Cell Types 2Delivering siRNAs to Difficult Cell Types 3Delivering siRNAs to Difficult Cell Types 4Delivering siRNAs to Difficult Cell Types 5Delivering siRNAs to Difficult Cell Types 6Delivering siRNAs to Difficult Cell Types 7New Tools for Small RNA Analysis 2New Tools for Small RNA Analysis 3New Tools for Small RNA Analysis 4New Tools for Small RNA Analysis 5New Tools for Small RNA Analysis 6New Tools for Small RNA Analysis 7New Tools for Small RNA Analysis 8
(Date:3/23/2015)... -- SoundView Technology Group issues a new research update following ... smart wallet. SoundView was one of the selected user groups to ... Wocket in multiple scenarios and outlets. Soundview ... making both debit and credit card payments.  ... company meets their plans in 2015, it would push our ...
(Date:3/20/2015)... , Mar. 20, 2015 Research and Markets ... addition of the "India Sensors Market Forecast ... The sensor market is projected to ... Consumer electronics, automotive, industrial and healthcare ... in the country. In addition, adoption of MEMS ...
(Date:3/19/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces its biometric payment technology, the Wocket® smart ... week on Washington DC,s Fox 5 ... "The Next Great Thing", host Laura Evans calls ... ,a really big breakthrough in mobile payment.,  ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... 8, 2013 Dr. Eric Olson , chairman of ... recipient of the March of Dimes Prize in Developmental Biology ... heart and other muscles. His work is credited with ... lead to novel treatments for heart disease and muscle dysfunction. ...
... granted whenever they flip on a light switch. But the ... States makes the on-demand delivery of electricity more challenging. ... virtually no storage capacity, so grid operators can,t stockpile surplus ... wind isn,t blowing. To provide more flexibility in managing ...
... , March 8, 2013  The following is being ... (Logo: http://photos.prnewswire.com/prnh/20111114/DC06171LOGO ) What:  ... media regarding new commercialization developments at Wake Forest Baptist ... briefing. Who: John ...
Cached Biology News:UTSW molecular biologist Olson wins March of Dimes developmental biology prize 2Stanford scientists calculate the carbon footprint of grid-scale battery technologies 2Stanford scientists calculate the carbon footprint of grid-scale battery technologies 3Stanford scientists calculate the carbon footprint of grid-scale battery technologies 4Stanford scientists calculate the carbon footprint of grid-scale battery technologies 5Wake Forest Innovations Announces New Commercialization Developments 2
... Region By immunoblotting the antibody reacts against ... with free MMP-2 or MMP-2 bound to ... glycerol solution Solution in 0.01 M ... glycerol and 15 mM sodium azide. synthetic ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ...
Acetylcholinesterase from human and monkey....
... Insulin exerts its effects ... insulin receptor, a disulfide-linked ... two Alpha subunits and ... in the following configuration: ...
Biology Products: